Phathom Pharmaceuticals (PHAT) Times Interest Earned (2018 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly Times Interest Earned came in at -$0.45 in Q1 2026, up 89.64% year-on-year from -$0.24 in Q1 2025, and down 25.23% on a QoQ basis from -$0.36 in Q4 2025.
Phathom Pharmaceuticals (PHAT) Times Interest Earned (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 9 years of Times Interest Earned data on file, last reported at -$0.45 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 89.64% year-over-year to -$0.45 in Q1 2026; TTM through Mar 2026 was -$2.82, a 29.45% increase from a year earlier, with the FY2025 full-year figure at -$1.99, down 82.87% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.45, down from -$0.36 in the prior quarter.
- Over the last five years, Times Interest Earned for PHAT reached as high as -$0.36 in Q4 2025 and fell as low as -$13.54 in Q1 2022.
- Historically, Times Interest Earned has averaged -$4.14 across 5 years, with a median of -$3.26 in 2023.
- Across the five-year window, Times Interest Earned tumbled 684.34% in 2022 and soared 89.64% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$12.27 in 2022, then surged by 83.13% to -$2.07 in 2023, then slumped by 54.33% to -$3.2 in 2024, then soared by 88.7% to -$0.36 in 2025, then decreased by 25.23% to -$0.45 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.45 in Q1 2026, -$0.36 in Q4 2025, and -$0.37 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Phathom Pharmaceuticals | 945.22 Mn | 761.46 Mn | 46.31 Mn | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.45 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -2.37 |
| Mar 31, 2025 | -4.36 |
| Dec 31, 2024 | -3.20 |
| Sep 30, 2024 | -1.37 |
| Jun 30, 2024 | -4.35 |
| Mar 31, 2024 | -4.07 |
| Dec 31, 2023 | -2.07 |
| Sep 30, 2023 | -3.53 |
| Jun 30, 2023 | -2.12 |
| Mar 31, 2023 | -3.26 |
| Dec 31, 2022 | -12.27 |
| Sep 30, 2022 | -4.58 |
| Jun 30, 2022 | -8.00 |
| Mar 31, 2022 | -13.54 |
| Dec 31, 2021 | -8.52 |
| Sep 30, 2021 | -1.08 |
| Jun 30, 2021 | -1.02 |